{"id":3531,"date":"2000-05-15T08:47:34","date_gmt":"2000-05-15T07:47:34","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=3531"},"modified":"2014-07-01T13:07:06","modified_gmt":"2014-07-01T13:07:06","slug":"abt-378r-lopinavir-now-available-on-named-patient-basis-in-uk","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/3531","title":{"rendered":"ABT-378\/r (lopinavir) now available on named patient basis in UK"},"content":{"rendered":"<p><strong>Abbott Laboratories have announced the availability of ABT-378\/r, a protease inhibitor still in development, on named patient basis in the UK.<\/strong><\/p>\n<p>Physicians may request supply of ABT-378\/r to individual patients and there are no restrictions in terms of patient criteria. This named patient program is in addition to the open-label safety evaluation study (M99-046UK) which also provides ABT-378\/r to patients meeting the study criteria.<\/p>\n<p>Physicians requiring further information, or needing to request ABT-378\/r for individual patients should contact the Named Patient Administrator on 01628 644370.<\/p>\n<p>Source: Abbott Laboratories, 4 April 2000<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abbott Laboratories have announced the availability of ABT-378\/r, a protease inhibitor still in development, on named patient basis in the UK. Physicians may request supply of ABT-378\/r to individual patients and there are no restrictions in terms of patient criteria. &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-3531","post","type-post","status-publish","format-standard","hentry","category-antiretrovirals"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/3531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=3531"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/3531\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=3531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=3531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=3531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}